Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine-Reference-Cited by-同舟云学术

Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine

Published:1995-01 Issue:1 Volume:13 Page:67-71
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Cryz S.J.,Goldstein H.,Pettoello-Mantovani M.,Kim A.,Fürer E.,Que J.U.,Hasler T.,Rubinstein A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference34 articles.

1. Type-specific neutralization of HIV with antibodies to env-encoded synthetic peptides;Palker,1988

2. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120;Rusche,1988

3. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees;Goudsmit,1988

4. Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain;Scott,1990

5. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160;Berman;Nature,1990

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide Vaccines;Topley & Wilson's Microbiology and Microbial Infections;2010-03-15

2. Bacterial Toxins: Potential Weapons Against HIV Infection;Current Pharmaceutical Design;2005-08-01

3. Induction of High Levels of Epitope-Specific Antibodies by Epitope/Peptide Candidate Vaccines against Human Immunodeficiency Virus Type-1 (HIV-1);Microbiology and Immunology;2000-02

4. Immunologic Responses of HIV-1–Infected Study Subjects to Immunization With a Mixture of Peptide Protein Derivative–V3 Loop Peptide Conjugates;JAIDS Journal of Acquired Immune Deficiency Syndromes;1999-12

5. Immunologic Responses of HIV-1–Infected Study Subjects to Immunization With a Mixture of Peptide Protein Derivative–V3 Loop Peptide Conjugates;Journal of Acquired Immune Deficiency Syndromes;1999-12